UroGen Pharma (URGN)
14.66
+0.29 (2.02%)
Upcoming Events
Latest Headlines
UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers
April 17, 2024 12:02 PM - BizWire
NorthStar Appoints Peter Pfreundschuh to Board of Managers
April 15, 2024 9:00 AM - BizWire
UroGen Pharma (URGN) Announces FDA Acceptance of Investigational New Drug Application for UGN-103
April 15, 2024 8:01 AM - StreetInsider
UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
April 15, 2024 8:00 AM - BizWire
UroGen Pharma (URGN) Files Patent Infringement Action Against Teva Pharmaceuticals (TEVA)
April 3, 2024 8:03 AM - StreetInsider
UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals
April 3, 2024 8:00 AM - BizWire
Form 4 UroGen Pharma Ltd. For: Mar 18 Filed by: Schoenberg Mark
March 20, 2024 4:39 PM - SEC Filing
Form 144 UroGen Pharma Ltd. Filed by: Schoenberg Mark
March 18, 2024 1:49 PM - SEC Filing
UroGen Pharma (URGN) PT Lowered to $34 at Oppenheimer
March 15, 2024 7:23 AM - StreetInsider
Form 10-K UroGen Pharma Ltd. For: Dec 31
March 14, 2024 8:18 AM - SEC Filing
Form 8-K UroGen Pharma Ltd. For: Mar 14
March 14, 2024 8:16 AM - SEC Filing
UroGen Pharma (URGN) Misses Q4 EPS by 4c ; Offers Guidance
March 14, 2024 8:03 AM - StreetInsider
UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102
March 14, 2024 8:00 AM - BizWire
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 8, 2024 8:00 AM - BizWire
UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024
March 4, 2024 8:00 AM - BizWire
Form 8-K UroGen Pharma Ltd. For: Mar 04
March 4, 2024 7:02 AM - SEC Filing
Form 8-K UroGen Pharma Ltd. For: Mar 01
March 1, 2024 7:01 AM - SEC Filing
UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference
February 26, 2024 8:00 AM - BizWire
Form SC 13D/A UroGen Pharma Ltd. Filed by: Arkin Moshe
February 22, 2024 9:24 AM - SEC Filing
Form SC 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
February 14, 2024 5:02 PM - SEC Filing
Form SC 13G/A UroGen Pharma Ltd. Filed by: GREAT POINT PARTNERS LLC
February 14, 2024 4:39 PM - SEC Filing
Form SC 13G/A UroGen Pharma Ltd. Filed by: MENORA MIVTACHIM HOLDINGS LTD.
February 14, 2024 10:02 AM - SEC Filing
Form SC 13G/A UroGen Pharma Ltd. Filed by: Stonepine Capital Management, LLC
February 14, 2024 10:02 AM - SEC Filing
Form SC 13G UroGen Pharma Ltd. Filed by: RTW INVESTMENTS, LP
February 14, 2024 7:08 AM - SEC Filing
Form 4/A UroGen Pharma Ltd. For: Jan 31 Filed by: Kim Dong
February 12, 2024 5:48 PM - SEC Filing
Form 4/A UroGen Pharma Ltd. For: Mar 25 Filed by: Kim Dong
February 12, 2024 5:43 PM - SEC Filing
Form 8-K UroGen Pharma Ltd. For: Feb 07
February 7, 2024 4:17 PM - SEC Filing
Form 4/A UroGen Pharma Ltd. For: Jan 31 Filed by: Smith Jason Drew
February 5, 2024 9:17 PM - SEC Filing
Form 4/A UroGen Pharma Ltd. For: Jan 31 Filed by: Schoenberg Mark
February 5, 2024 9:15 PM - SEC Filing
Form 4 UroGen Pharma Ltd. For: Jan 31 Filed by: Smith Jason Drew
February 2, 2024 7:13 PM - SEC Filing
Form 4 UroGen Pharma Ltd. For: Jan 31 Filed by: Schoenberg Mark
February 2, 2024 7:08 PM - SEC Filing
Form 4 UroGen Pharma Ltd. For: Jan 31 Filed by: Kim Dong
February 2, 2024 7:06 PM - SEC Filing
Form 4 UroGen Pharma Ltd. For: Jan 31 Filed by: Barrett Elizabeth A.
February 2, 2024 7:04 PM - SEC Filing
Form SC 13G UroGen Pharma Ltd. Filed by: BlackRock Inc.
February 2, 2024 2:19 PM - SEC Filing
Form 144 UroGen Pharma Ltd. Filed by: Schoenberg Mark
February 1, 2024 10:14 AM - SEC Filing
Form 144 UroGen Pharma Ltd. Filed by: Smith Jason Drew
February 1, 2024 9:53 AM - SEC Filing
UroGen Pharma to Participate at Upcoming Investor Conferences
February 1, 2024 8:00 AM - BizWire
UroGen Pharma (URGN) Initiates Submission of a Rolling NDA to the FDA for UGN-102
January 24, 2024 8:00 AM - StreetInsider
UroGen Initiates Submission of a Rolling NDA to the FDA for UGN-102
January 24, 2024 8:00 AM - BizWire
UroGen Pharma (URGN) PT Raised to $35 at Oppenheimer
January 24, 2024 5:35 AM - StreetInsider
Full Article List
